124 related articles for article (PubMed ID: 6777166)
1. The effects of Corynebacterium parvum in dogs and a study of its distribution following intravenous injection.
Owen LN; Lewis JC; Morgan DR; Gorman NT
Eur J Cancer (1965); 1980 Aug; 16(8):999-1005. PubMed ID: 6777166
[No Abstract] [Full Text] [Related]
2. Corynebacterium parvum as a therapeutic antitumor agent in mice. I. Systemic effects from intravenous injection.
Scott MT
J Natl Cancer Inst; 1974 Sep; 53(3):855-60. PubMed ID: 4213015
[No Abstract] [Full Text] [Related]
3. Effect of the combination of Corynebacterium parvum and levamisole on murine tumors.
Anaclerio A; Conti G; Moras ML; Barale C; Spreafico F
Eur J Cancer (1965); 1977 Dec; 13(12):1451-53. PubMed ID: 413718
[No Abstract] [Full Text] [Related]
4. Antitumor activity of Corynebacterium parvum.
Milas L; Scott MT
Adv Cancer Res; 1978; 26():257-306. PubMed ID: 343523
[No Abstract] [Full Text] [Related]
5. Incomplete surgery, local immunostimulation, and recurrence of some tumour types in dogs and cats.
Misdorp W
Vet Q; 1987 Jul; 9(3):279-86. PubMed ID: 3118558
[TBL] [Abstract][Full Text] [Related]
6. Role of Corynebacterium parvum in the activation of peritoneal macrophages. 1. Association between intracellular C. parvum and cytotoxic macrophages.
Chapes SK; Haskill S
Cell Immunol; 1982 Jun; 70(1):65-75. PubMed ID: 7116464
[No Abstract] [Full Text] [Related]
7. Effects of Corynebacterium parvum vaccine in conjunction with immunosuppression in renal transplant in dogs.
Munda R; Alexander JW; Stinnett JD; Weiss MA; Morris MJ
Transplantation; 1982 Mar; 33(3):333-5. PubMed ID: 7039044
[No Abstract] [Full Text] [Related]
8. [Mechanism of the antitumor immunity potentiated by anaerobic Corynebacterium parvum].
Miyata H
Fukuoka Igaku Zasshi; 1983 Jul; 74(7):451-69. PubMed ID: 6662469
[No Abstract] [Full Text] [Related]
9. Effects of Corynebacterium parvum after intraperitoneal injection in hamsters.
Duthu A; Alexandrov I; Le Goffic N; De Vaux St Cyr C
Dev Comp Immunol; 1984; 8(1):231-6. PubMed ID: 6233193
[No Abstract] [Full Text] [Related]
10. Suppressor T cells and suppressor macrophages induced by Corynebacterium parvum.
Lichtenstein A; Murahata R; Sugasawara R; Zighelboim J
Cell Immunol; 1981 Mar; 58(2):257-68. PubMed ID: 6452218
[No Abstract] [Full Text] [Related]
11. Corynebacterium parvum as a therapeutic antitumor agent in mice. II. Local injection.
Scott MT
J Natl Cancer Inst; 1974 Sep; 53(3):861-5. PubMed ID: 4213016
[No Abstract] [Full Text] [Related]
12. Canine oral melanoma: comparison of surgery versus surgery plus Corynebacterium parvum.
MacEwen EG; Patnaik AK; Harvey HJ; Hayes AA; Matus R
Cancer Invest; 1986; 4(5):397-402. PubMed ID: 3801954
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy of cancer with corynebacterium parvum.
Halpern B
Ann Allergy; 1978 Mar; 40(3):155-7. PubMed ID: 637374
[No Abstract] [Full Text] [Related]
14. Failure of Corynebacterium parvum presensitization to modify the antitumor effects of systemic and local therapeutic injections of C. parvum in mice.
Scott MT
J Natl Cancer Inst; 1976 Mar; 56(3):675-7. PubMed ID: 815560
[TBL] [Abstract][Full Text] [Related]
15. Surgery plus Corynebacterium parvum immunotherapy for Lewis lung carcinoma in mice.
Karrer K; Rella W; Goldin A
Eur J Cancer (1965); 1979 Jun; 15(6):867-73. PubMed ID: 499275
[No Abstract] [Full Text] [Related]
16. Enhanced Fc receptor expression by a sub-population of murine intra-tumour macrophages following intravenous Corynebacterium parvum therapy.
Moore K; McBride WH
Br J Cancer; 1983 Jun; 47(6):797-802. PubMed ID: 6860547
[TBL] [Abstract][Full Text] [Related]
17. Studies with a spontaneous mouse tumor. I. Growth in normal mice and response to Corynebacterium parvum.
Woodruff MF; Whitehead VL; Speedy G
Br J Cancer; 1978 Mar; 37(3):345-55. PubMed ID: 638014
[TBL] [Abstract][Full Text] [Related]
18. Corynebacterium parvum enhances colonic cancer in dimethylhydrazine-treated rats.
Cruse JP; Lewin MR; Clark CG
Br J Cancer; 1978 Apr; 37(4):639-43. PubMed ID: 646934
[No Abstract] [Full Text] [Related]
19. Lack of immunological and anti-tumour effects of orally administered Corynebacterium papvum in mice.
Sadler TE; Castro JE
Br J Cancer; 1975 Mar; 31(3):359-63. PubMed ID: 1156520
[No Abstract] [Full Text] [Related]
20. [The use of Corynebacterium parvum in pleurodesis].
Helin T; Haahtela T
Duodecim; 1988; 104(4):262-5. PubMed ID: 3168834
[No Abstract] [Full Text] [Related]
[Next] [New Search]
